People: Texas Instruments Inc (TXN.O)
13 Sep 2019
Ms. Carrie S. Cox is Independent Director of Texas Instruments Incorporated. Ms. Cox has gained first-hand experience managing large, multinational organizations focused on medical-related markets, with responsibility for those organizations’ financial performance and significant capital and R&D investments, as chairman (2013-present), CEO (2010-2018) and a director (2010-present) of Humacyte, Inc., executive vice president and president of Global Pharmaceuticals at Schering-Plough Corporation (2003-2009) and executive vice president and president of Global Prescription Business at Pharmacia Corporation (1997-2003). Ms. Cox is also a chairman of the board of Array BioPharma, Inc. (2018-present) and ElectroCore, Inc. (2018-present) and a director of Cardinal Health, Inc. (2009-present) and Celgene Corporation (2009-present).
|Total Annual Compensation, USD||85,000|
|Restricted Stock Award, USD||99,906|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||115,374|
|Fiscal Year Total, USD||300,280|